INTERNATIONAL FORUM ON HPV AND HEAD & NECK CANCER
MONday, JAN. 18, 2021 • TUESday, JAN. 19, 2021
Coordination: E. RETTIG (USA), P. KLUSSMANN (Germany)
The EUROGIN HPV and Head & Neck Cancer Forum highlights areas of active investigation in the field of HPV and head and neck cancers. This year's forum will offer an extended review of screening for early cancer detection that will occupy two sessions, molecular characterization and potential biomarkers for prognosis and monitoring of HPV related oropharyngeal cancer patients, new insights on emerging treatment strategies and the role of HPV in benign disease such as recurrent respiratory papillomatosis
A dedicated debate session will focus on the controversies regarding the impact of HPV infection on oro-pharyngeal cancer, including diagnosis, management and decision making.
Overview of Sessions
Subject to change
Monday, January 18, 2021
- Management of HPV related HN diseases (diagnosis, deintensification, role of biomarkers, high-risk and recurrent disease)
- Screening for HPV-OPC (risk-stratified screening, cost-effectiveness, screening trial updates, early marker)
- Epidemiology and prevention (epidemiological trends, biomarkers, HPV vaccination, …)
- Survivorship & surveillance(HPV-OPC surveillance, patient concerns, priorities, deintensification, psychology, …)
- Submitted papers
Tuesday, January 19, 2021
- Carinogenesis and molecular characterization (Smoking vs. HPV, viral integration, molecular modifiers, liquid biopsy, …)
- Immunologic considerations
- RRP (immune therapy, vaccination, …)
- Submitted papers
EUROGIN (EUropean Research Organisation on Genital Infection and Neoplasia) brings together clinicians and scientists whose work is related to genital infections and neoplasia.
